Phosphorylated CDK9-Tyr19 can increase its kinase activity and nuclear localization, stabilize positive transcription elongation factor b, and activate the transcription of HR repair genes dependent on polymerase II, thus promote homologous recombination (HR) repair and increase tumor resistance to PARP inhibitors. This evidence concerns the gene CDK9 and neoplasm.